Single Rising Dose Trial of Spesolimab (BI 655130) for Healthy Japanese Male Subjects
Clinical trial NCT03123094 · COMPLETED
Trial details
- NCT number
- NCT03123094
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-16
- Primary completion
- 2018-01-04
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.